Kyodo Pharmaceutical (300966.SZ): Net profit in the first quarter was 3.5473 million yuan, a year-on-year decrease of 11.86%

stock analyst • • US Stocks Focus

Gelonghui April 25 | Kyodo Pharmaceutical (300966.SZ) announced the first quarter report of 2024. The operating income during the reporting period was 122 million yuan, a year-on-year increase of 2.35%; the net profit attributable to shareholders of the listed company was 3.5473 million yuan, a year-on-year decrease. 11.86%; net profit excluding non-recurring gains and losses attributable to shareholders of listed companies was 3.4646 million yuan, a year-on-year increase of 2,911.68%; basic earnings per share was 0.03 yuan.

Gelonghui April 25 | Kyodo Pharmaceutical (300966.SZ) announced the first quarter report of 2024. The operating income during the reporting period was 122 million yuan, a year-on-year increase of 2.35%; the net profit attributable to shareholders of the listed company was 3.5473 million yuan, a year-on-year decrease. 11.86%; net profit excluding non-recurring gains and losses attributable to shareholders of listed companies was 3.4646 million yuan, a year-on-year increase of 2,911.68%; basic earnings per share was 0.03 yuan.

Like (0)
stock analyststock analyst
Previous April 25, 2024 7:59 pm
Next April 25, 2024 7:59 pm

Related posts

  • BBAE analyst Huang Shaoping was at the Markel Annual Meeting: Compared with the Berkshire Annual Meeting, this place is smaller, more beautiful and warmer

    Sina_text_page_info [\’videodatas0\’] = [{ad_state: \’1\’, pid: \’1\’, video_id: 530050562, // vidpic: \’//wx3.sinaimg.cn/007zwukjly1hp zgdl110EJ30ZK0K0MYO_220_124.jpg \’, // The show list is small Picture thumbUrl: \’//wx3.sinaimg.cn/orj480/007ZwuKJly1hpzgdl110ej30zk0k0myo.jpg\’, //The picture displayed on the HTML5 player before the video has started playing, can be the same as the pic title: \’BBAE analyst Huang Shaoping at the Markle annual meeting On-site: Compared with the Berkshire Annual Meeting, this place is smaller, more beautiful and warmer\’,//Title source: \’\’,//Video release source

    US Stocks Focus May 23, 2024

  • It’s time for next-gen capital market reforms: CEA Anantha Nageswaran

    Time has come for India to look at the next generation of capital market reforms that would particularly focus on shaping the country’s future debt market, Anantha Nageswaran, Chief Economic Advisor to the Finance Ministry, said on Friday.

    US Stocks Focus May 19, 2024

  • IPO screener.Aadhar Housing IPO : Blackstone-backed company to list shares today

    Shares of Aadhar Housing Finance will make their debut on the bourses on Wednesday. The company has fixed the IPO price at ₹315, at the upper end of the price range of ₹300-315.

    US Stocks Focus May 15, 2024

  • F&O Tracker: Outlook turns uncertain as index futures consolidate

    Nifty 50 (23,466) and Bank Nifty (50,002) gained by a marginal 0.8 per cent and 0.4 per cent last week. While the derivatives data of Nifty 50 gives it a bullish inclination, Bank Nifty’s data gives more of a flattish signal. Below is an analysis.

    US Stocks Focus June 18, 2024

  • The first regional airline stock has made a strong reversal!

    Since entering 2023, the civil aviation industry has accelerated its recovery, and all civil aviation has achieved significant reductions in losses.

    US Stocks Focus April 25, 2024

  • JPMorgan strategist says earnings report unlikely to boost stocks

    JPMorgan Chase & Co. strategists say don’t expect an upbeat corporate earnings season to drive stocks higher because much of the optimism has already been priced in after this year’s record gains. A research team led by Mislav Matejka wrote in a report that profit expectations for the first quarter have been lowered during the reporting period, which lowers the threshold for U.S. companies to exceed expectations. Strategists said that after excluding technology giants, S&P 500 companies’ profits are expected to decline across the board. At the same time, investor positions look “very stretched,” Matejka said, with major stock indexes hitting record highs on optimism about economic growth and interest rate cuts. He said: “The stock market has performed well post-earnings, suggesting investors are more optimistic than the pessimistic earnings forecasts conveyed by sell-side analysts. We need to see significant earnings acceleration to justify current stock valuations “It’s reasonable and we’re concerned that this may not happen.” Matejka said that so far, half of U.S. companies have performed below market expectations on the day of earnings reports. Despite a 10%…

    US Stocks Focus April 15, 2024